-- Huadong Medicine (SHE:000963) said China's drug administrator accepted its marketing application for semaglutide injection.
The drug is used for long-term weight management in obese or overweight adults, according to a Wednesday filing with the Shenzhen bourse.
Shares of the drugmaker closed 2% higher Wednesday.